Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis
Deja R Rose(Cleveland Clinic), Brandon Moss(Cleveland Clinic), Ahmad Mahadeen(Cleveland Clinic), Jeffrey A. Cohen(Cleveland Clinic), J Sedlák(Cleveland Clinic), Alise Carlson(Cleveland Clinic), Robert A Bermel(Cleveland Clinic), Scott Husak(Cleveland Clinic), Sarah M. Planchon(Cleveland Clinic)
Multiple Sclerosis Journal - Experimental Translational and Clinical
October 1, 2021
Cited by 18
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
How patients with multiple sclerosis acquire disability
|Brain|2022|532
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis
|Annals of Neurology|2011|390
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
|The Lancet Neurology|2025|314